172 related articles for article (PubMed ID: 34138248)
1. CaCO
Zhu Y; Yang Z; Dong Z; Gong Y; Hao Y; Tian L; Yang X; Liu Z; Feng L
Nanomicro Lett; 2020 Nov; 13(1):29. PubMed ID: 34138248
[TBL] [Abstract][Full Text] [Related]
2. Aptamer-conjugated nano-liposome for immunogenic chemotherapy with reversal of immunosuppression.
Kim M; Lee JS; Kim W; Lee JH; Jun BH; Kim KS; Kim DE
J Control Release; 2022 Aug; 348():893-910. PubMed ID: 35760233
[TBL] [Abstract][Full Text] [Related]
3. Acidic/hypoxia dual-alleviated nanoregulators for enhanced treatment of tumor chemo-immunotherapy.
Guo X; Chen X; Ding J; Zhang F; Chen S; Hu X; Fang S; Shen L; Lu C; Zhao Z; Tu J; Shu G; Chen M; Ji J
Asian J Pharm Sci; 2024 Apr; 19(2):100905. PubMed ID: 38595332
[TBL] [Abstract][Full Text] [Related]
4. Photothermal MnO
Chen Z; Zhang Q; Huang Q; Liu Z; Zeng L; Zhang L; Chen X; Song H; Zhang J
Int J Pharm; 2022 Apr; 617():121578. PubMed ID: 35176333
[TBL] [Abstract][Full Text] [Related]
5. Oxaliplatin-/NLG919 prodrugs-constructed liposomes for effective chemo-immunotherapy of colorectal cancer.
Shen F; Feng L; Zhu Y; Tao D; Xu J; Peng R; Liu Z
Biomaterials; 2020 Oct; 255():120190. PubMed ID: 32563943
[TBL] [Abstract][Full Text] [Related]
6. Dendritic Nanomedicine with Boronate Bonds for Augmented Chemo-Immunotherapy via Synergistic Modulation of Tumor Immune Microenvironment.
Li Y; Wu Y; Fang Z; Zhang Y; Ding H; Ren L; Zhang L; Gong Q; Gu Z; Luo K
Adv Mater; 2024 Jan; 36(2):e2307263. PubMed ID: 37743633
[TBL] [Abstract][Full Text] [Related]
7. Breast Cancer Chemo-immunotherapy through Liposomal Delivery of an Immunogenic Cell Death Stimulus Plus Interference in the IDO-1 Pathway.
Lu J; Liu X; Liao YP; Wang X; Ahmed A; Jiang W; Ji Y; Meng H; Nel AE
ACS Nano; 2018 Nov; 12(11):11041-11061. PubMed ID: 30481959
[TBL] [Abstract][Full Text] [Related]
8. Coordination Polymer-Coated CaCO
Wang C; Dong Z; Hao Y; Zhu Y; Ni J; Li Q; Liu B; Han Y; Yang Z; Wan J; Yang K; Liu Z; Feng L
Adv Mater; 2022 Jan; 34(3):e2106520. PubMed ID: 34773309
[TBL] [Abstract][Full Text] [Related]
9. Blockage of the IDO1 pathway by charge-switchable nanoparticles amplifies immunogenic cell death for enhanced cancer immunotherapy.
Shi M; Zhang J; Wang Y; Han Y; Zhao X; Hu H; Qiao M; Chen D
Acta Biomater; 2022 Sep; 150():353-366. PubMed ID: 35843594
[TBL] [Abstract][Full Text] [Related]
10. Nanoenabled Reversal of IDO1-Mediated Immunosuppression Synergizes with Immunogenic Chemotherapy for Improved Cancer Therapy.
Huang H; Jiang CT; Shen S; Liu A; Gan YJ; Tong QS; Chen SB; Gao ZX; Du JZ; Cao J; Wang J
Nano Lett; 2019 Aug; 19(8):5356-5365. PubMed ID: 31286779
[TBL] [Abstract][Full Text] [Related]
11. Polymeric indoximod based prodrug nanoparticles with doxorubicin entrapment for inducing immunogenic cell death and improving the immunotherapy of breast cancer.
Zang X; Song J; Yi X; Piyu J
J Mater Chem B; 2022 Mar; 10(12):2019-2027. PubMed ID: 35254372
[TBL] [Abstract][Full Text] [Related]
12. Tumor microenvironment-responsive spherical nucleic acid nanoparticles for enhanced chemo-immunotherapy.
Ma B; Ma Y; Deng B; Xiao P; Huang P; Wang D; Liu L
J Nanobiotechnology; 2023 May; 21(1):171. PubMed ID: 37237292
[TBL] [Abstract][Full Text] [Related]
13. A tumor extracellular pH-sensitive PD-L1 binding peptide nanoparticle for chemo-immunotherapy of cancer.
Zhu W; Bai Y; Zhang N; Yan J; Chen J; He Z; Sun Q; Pu Y; He B; Ye X
J Mater Chem B; 2021 May; 9(20):4201-4210. PubMed ID: 33997867
[TBL] [Abstract][Full Text] [Related]
14. Charge-switchable nanoparticles enhance Cancer immunotherapy based on mitochondrial dynamic regulation and immunogenic cell death induction.
Zhao M; Li J; Liu J; Xu M; Ji H; Wu S; Chen D; Hu H
J Control Release; 2021 Jul; 335():320-332. PubMed ID: 34062192
[TBL] [Abstract][Full Text] [Related]
15. Binary Cooperative Prodrug Nanoparticles Improve Immunotherapy by Synergistically Modulating Immune Tumor Microenvironment.
Feng B; Zhou F; Hou B; Wang D; Wang T; Fu Y; Ma Y; Yu H; Li Y
Adv Mater; 2018 Sep; 30(38):e1803001. PubMed ID: 30063262
[TBL] [Abstract][Full Text] [Related]
16. Precise delivery of doxorubicin and imiquimod through pH-responsive tumor microenvironment-active targeting micelles for chemo- and immunotherapy.
Wen YH; Hsieh PI; Chiu HC; Chiang CW; Lo CL; Chiang YT
Mater Today Bio; 2022 Dec; 17():100482. PubMed ID: 36388459
[TBL] [Abstract][Full Text] [Related]
17. Enhancing TNBC Chemo-immunotherapy via combination reprogramming tumor immune microenvironment with Immunogenic Cell Death.
Wu S; Liu D; Li W; Song B; Chen C; Chen D; Hu H
Int J Pharm; 2021 Apr; 598():120333. PubMed ID: 33540008
[TBL] [Abstract][Full Text] [Related]
18. Bioresponsive and immunotherapeutic nanomaterials to remodel tumor microenvironment for enhanced immune checkpoint blockade.
Fang T; Cao X; Wang L; Chen M; Deng Y; Chen G
Bioact Mater; 2024 Feb; 32():530-542. PubMed ID: 38026439
[TBL] [Abstract][Full Text] [Related]
19. Lipid-Coated CaCO
Xu Y; Wang C; Shen F; Dong Z; Hao Y; Chen Y; Liu Z; Feng L
ACS Appl Bio Mater; 2022 Mar; 5(3):1194-1201. PubMed ID: 35179344
[TBL] [Abstract][Full Text] [Related]
20. Folated pH-degradable nanogels for the simultaneous delivery of docetaxel and an IDO1-inhibitor in enhancing cancer chemo-immunotherapy.
Qiao H; Chen X; Chen E; Zhang J; Huang D; Yang D; Ding Y; Qian H; Feijen J; Chen W
Biomater Sci; 2019 Jun; 7(7):2749-2758. PubMed ID: 30997445
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
